認定SMDの日下さんがドバイでの国際会議で表彰されました !

今年、国際認定SMDを取得した日下春樹さん(ジェイファーマ株式会社)が6月にドバイで開催されたHealth 2.0 ConferenceでOutstanding Leadership Awardを受賞されました。SMD認定を取得後、日下さんのもとには海外からも連絡が入るようになり、SMD認定取得と業務での取組みが評価されて、ヘルスケアの国際カンファレンスでの表彰に繋がったそうです。
医薬品開発専門家としての認定を持っていることは、会社としても対外的に証明できるものであり、今後は社内にも認定取得者を増やしたいとのことです。
*Link to J-Pharma news page: https://www.j-pharma.com/en/news_list/842/



English edition
Title: Mr Haruki Kusaka(Director of Clinical Development Department, J-Pharma Co., Ltd), certified SMD by PharmaTrain Federation and IFAPP, got celebrated at Health 2.0 Conference (held in Dubai, UAE) for his outstanding leadership
Message:Mr Kusana received SMD certificate (Specialist in Medicines Development) earlier in 2023, is awarded at the international healthcare conference in June 2023 for his dedicated contribution of a first-in-class drug development. Since his SMD certification, he started to receive overseas correnspondence. His presence as an internationally certified and awarded specialist can evidently show his office as the corporate of excellence, he is now hopeful to develop more SMDs in his workplace.
*Link to J-Pharma news page: https://www.j-pharma.com/en/news_list/842/